STAT3 activation
Cédric Rébé, Frédérique Végran, Hélène Berger et al. · JAK-STAT · 2013
Cancer growth is controlled by cancer cells (cell intrinsic phenomenon), but also by the immune cells in the tumor microenvironment (cell extrinsic phenomenon). Thus cancer progression is mediated by the activation of transcription programs responsible for cancer cell proliferation, but also induced proliferation/activation of immunosuppressive cells such as Th17, Treg or myeloid derived suppressor cells (MDSCs). One of the key transcription factors involved in these pathways is the signal transducer and activator of transcription 3 (STAT3). In this review we will focus on STAT3 activation in immune cells, and how it impacts on tumor progression.
Cited by 212 works. doi:10.4161/jkst.23010 Open-access PDF
Authors
References
- The Dendritic Cell System and its Role in Immunogenicity
- Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
- Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
- CD4+CD25+ suppressor T cells: more questions than answers
- A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
- Myeloid-derived suppressor cells as regulators of the immune system
- Regulatory T Cells